Categories: Health

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

 | Source: IRIDEX Corporation

MOUNTAIN VIEW, Calif., March 13, 2025 (GLOBE NEWSWIRE) — Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of glaucoma and retinal diseases, today announced the Company plans to release financial results for the fourth quarter and full year 2024 and provide a business update after the close of trading on Thursday, March 27, 2025.

The Company’s management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing +1-888-596-4144 and providing conference ID: 5685253. A live and recorded webcast on the “Event Calendar” page of the “Investors” section of the Company’s website at www.iridex.com.

About Iridex Corporation

Iridex Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma and diabetic macular edema (DME) and other retinal diseases. Iridex products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. For further information, visit the Iridex website at www.iridex.com.

MicroPulse® is a registered trademark of Iridex Corporation, Inc. in the United States, Europe and other jurisdictions. © 2025 Iridex Corporation. All rights reserved.

Investor Relations Contact:
Philip Taylor
Gilmartin Group
investors@iridex.com

GlobeNews Wire

Recent Posts

Phunware Reports First Quarter 2025 Financial Results

May 12, 2025 16:05 ET  | Source: Phunware, Inc. New Customer Launches Drive 40% Revenue…

2 hours ago

Rapid7 Announces First Quarter 2025 Financial Results

Annualized recurring revenue (“ARR”) of $837 million, an increase of 4% year-over-yearTotal revenue of $210…

2 hours ago

Lantronix Appoints Sailesh Chittipeddi to Its Board of Directors

IRVINE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader…

2 hours ago

OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

Q1 revenue of $21.9 million, increasing 11% year-over-yearQ1 gross profit increased 9% year-over-year to $13.3 millionIncreases…

2 hours ago

GigaCloud Technology Inc Announces First Quarter Ended March31, 2025 Financial Results

Continued B2B Marketplace Expansion and Proven Strength of the SFR Model May 12, 2025 16:05…

2 hours ago

Ascend begins production of high-purity acrylonitrile

HOUSTON, May 12, 2025 /PRNewswire/ -- Ascend Performance Materials announced today the production of high-purity acrylonitrile at…

2 hours ago